Business Description
Cancer is a complex disease, and we at OncoStem develop tests that help to identify patterns of cancer recurrence risk. An understanding of these patterns ensures that patients receive personalized therapies and treatments that are best suited to their condition.
Founded in 2011, OncoStem aims to develop innovative tests to personalize treatment for cancer patients. Understanding of tumor biology aids physicians in optimizing therapy for cancer patients. Our flagship product CanAssist Breast has been launched for breast cancer. Currently, we are working on similar tests for other cancer types including oral and ovarian cancer. Research is underway towards identifying and characterizing novel drug targets for breast and oral cancer.
